COSTEM 2019 | Is haploidentical the best curative option for sickle cell disease?

Miguel Abboud

Miguel Abbout, MD, American University of Beirut, Beirut, Lebanon, evaluates whether haploidentical stem cell transplantation is the best curative option for sickle cell disease at the 5th International Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM) 2019, held in Berlin, Germany.

Share this video  
Similar topics